These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34544500)

  • 1. Using informative features in machine learning based method for COVID-19 drug repurposing.
    Aghdam R; Habibi M; Taheri G
    J Cheminform; 2021 Sep; 13(1):70. PubMed ID: 34544500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
    Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
    BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topological network based drug repurposing for coronavirus 2019.
    Habibi M; Taheri G
    PLoS One; 2021; 16(7):e0255270. PubMed ID: 34324563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
    Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential pan-coronavirus therapies using a computational drug repurposing platform.
    Hwang W; Han N
    Methods; 2022 Jul; 203():214-225. PubMed ID: 34767922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing.
    Habibi M; Taheri G; Aghdam R
    Sci Rep; 2021 Apr; 11(1):9378. PubMed ID: 33931664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates.
    Rodrigues L; Bento Cunha R; Vassilevskaia T; Viveiros M; Cunha C
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives for repurposing drugs for the coronavirus disease 2019.
    Cherian SS; Agrawal M; Basu A; Abraham P; Gangakhedkar RR; Bhargava B
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):160-171. PubMed ID: 32317408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network bioinformatics analysis provides insight into drug repurposing for COVID-19.
    Li X; Yu J; Zhang Z; Ren J; Peluffo AE; Zhang W; Zhao Y; Wu J; Yan K; Cohen D; Wang W
    Med Drug Discov; 2021 Jun; 10():100090. PubMed ID: 33817623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method.
    Taheri G; Habibi M
    Appl Soft Comput; 2022 Oct; 128():109510. PubMed ID: 35992221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
    Su X; Hu L; You Z; Hu P; Wang L; Zhao B
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms.
    Taheri G; Habibi M
    Sci Rep; 2023 Sep; 13(1):15141. PubMed ID: 37704748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19.
    Ansari MA; Jamal QMS; Rehman S; Almatroudi A; Alzohairy MA; Alomary MN; Tripathi T; Alharbi AH; Adil SF; Khan M; Shaheer Malik M
    Arab J Chem; 2020 Nov; 13(11):8069-8079. PubMed ID: 34909057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages.
    Wang X; Wang H; Yin G; Zhang YD
    Heliyon; 2023 Mar; 9(3):e14059. PubMed ID: 36855680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A deep learning ensemble approach to prioritize antiviral drugs against novel coronavirus SARS-CoV-2 for COVID-19 drug repurposing.
    K D; A S J; Liu Y
    Appl Soft Comput; 2021 Dec; 113():107945. PubMed ID: 34630000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.